Quick Heal Technologies Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Kailash Katkar
Chief executive officer
₹17.3m
Total compensation
| CEO salary percentage | 100.00% |
| CEO tenure | 10.3yrs |
| CEO ownership | 21.3% |
| Management average tenure | 2.4yrs |
| Board average tenure | 5.4yrs |
Recent management updates
Recent updates
Optimistic Investors Push Quick Heal Technologies Limited (NSE:QUICKHEAL) Shares Up 30% But Growth Is Lacking
Jul 03
Quick Heal Technologies Limited's (NSE:QUICKHEAL) Business Is Yet to Catch Up With Its Share Price
May 18These Return Metrics Don't Make Quick Heal Technologies (NSE:QUICKHEAL) Look Too Strong
Apr 10Quick Heal Technologies Limited's (NSE:QUICKHEAL) 29% Share Price Plunge Could Signal Some Risk
Jan 28Quick Heal Technologies Limited (NSE:QUICKHEAL) May Have Run Too Fast Too Soon With Recent 26% Price Plummet
Nov 13Impressive Earnings May Not Tell The Whole Story For Quick Heal Technologies (NSE:QUICKHEAL)
Oct 25Revenues Not Telling The Story For Quick Heal Technologies Limited (NSE:QUICKHEAL) After Shares Rise 27%
Sep 05Quick Heal Technologies' (NSE:QUICKHEAL) Returns On Capital Tell Us There Is Reason To Feel Uneasy
Jul 23Revenues Not Telling The Story For Quick Heal Technologies Limited (NSE:QUICKHEAL) After Shares Rise 26%
Jul 05Quick Heal Technologies Limited's (NSE:QUICKHEAL) Share Price Not Quite Adding Up
Jan 17Quick Heal Technologies (NSE:QUICKHEAL) Is Paying Out Less In Dividends Than Last Year
Jul 23Quick Heal Technologies' (NSE:QUICKHEAL) Returns On Capital Not Reflecting Well On The Business
Apr 06We Like These Underlying Return On Capital Trends At Quick Heal Technologies (NSE:QUICKHEAL)
Jan 26Most Shareholders Will Probably Agree With Quick Heal Technologies Limited's (NSE:QUICKHEAL) CEO Compensation
Jul 30Investors Will Want Quick Heal Technologies' (NSE:QUICKHEAL) Growth In ROCE To Persist
May 31Does Quick Heal Technologies' (NSE:QUICKHEAL) CEO Salary Compare Well With The Performance Of The Company?
Feb 17Are Quick Heal Technologies Limited's (NSE:QUICKHEAL) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Feb 04
Should We Be Excited About The Trends Of Returns At Quick Heal Technologies (NSE:QUICKHEAL)?
Jan 17If You Had Bought Quick Heal Technologies' (NSE:QUICKHEAL) Shares Three Years Ago You Would Be Down 49%
Dec 28What Type Of Shareholders Make Up Quick Heal Technologies Limited's (NSE:QUICKHEAL) Share Registry?
Dec 10Need To Know: Quick Heal Technologies Limited (NSE:QUICKHEAL) Insiders Have Been Selling Shares
Nov 22Key Things To Watch Out For If You Are After Quick Heal Technologies Limited's (NSE:QUICKHEAL) 2.5% Dividend
Nov 02Will Quick Heal Technologies (NSE:QUICKHEAL) Multiply In Value Going Forward?
Oct 15Reflecting on Quick Heal Technologies' (NSE:QUICKHEAL) Share Price Returns Over The Last Three Years
Sep 28Is Quick Heal Technologies Limited's (NSE:QUICKHEAL) Latest Stock Performance A Reflection Of Its Financial Health?
Sep 07A Look At The Fair Value Of Quick Heal Technologies Limited (NSE:QUICKHEAL)
Aug 20CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | -₹7m |
| Jun 30 2025 | n/a | n/a | -₹45m |
| Mar 31 2025 | ₹17m | ₹17m | ₹50m |
| Dec 31 2024 | n/a | n/a | ₹223m |
| Sep 30 2024 | n/a | n/a | ₹323m |
| Jun 30 2024 | n/a | n/a | ₹410m |
| Mar 31 2024 | ₹14m | ₹14m | ₹242m |
| Dec 31 2023 | n/a | n/a | ₹36m |
| Sep 30 2023 | n/a | n/a | -₹158m |
| Jun 30 2023 | n/a | n/a | -₹65m |
| Mar 31 2023 | ₹17m | ₹14m | ₹64m |
| Dec 31 2022 | n/a | n/a | ₹411m |
| Sep 30 2022 | n/a | n/a | ₹647m |
| Jun 30 2022 | n/a | n/a | ₹772m |
| Mar 31 2022 | ₹16m | ₹13m | ₹832m |
| Dec 31 2021 | n/a | n/a | ₹948m |
| Sep 30 2021 | n/a | n/a | ₹940m |
| Jun 30 2021 | n/a | n/a | ₹882m |
| Mar 31 2021 | ₹13m | ₹12m | ₹1b |
| Dec 31 2020 | n/a | n/a | ₹752m |
| Sep 30 2020 | n/a | n/a | ₹796m |
| Jun 30 2020 | n/a | n/a | ₹875m |
| Mar 31 2020 | ₹13m | ₹12m | ₹744m |
| Dec 31 2019 | n/a | n/a | ₹942m |
| Sep 30 2019 | n/a | n/a | ₹922m |
| Jun 30 2019 | n/a | n/a | ₹976m |
| Mar 31 2019 | ₹15m | ₹12m | ₹918m |
Compensation vs Market: Kailash's total compensation ($USD192.34K) is about average for companies of similar size in the Indian market ($USD197.42K).
Compensation vs Earnings: Kailash's compensation has increased whilst the company is unprofitable.
CEO
Kailash Katkar (59 yo)
Dr. Kailash Sahebrao Katkar Co-Founded Quick Heal Technologies Limited in 1993 and serves as its Chairman of the Board and Managing Director. Dr. Katkar served as Chief Executive Officer at Quick Heal Tech...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | no data | ₹17.30m | 21.29% ₹ 3.1b | |
| Co-Founder | no data | ₹16.80m | 35.78% ₹ 5.2b | |
| Chief Financial Officer | 2.7yrs | ₹11.40m | 0.083% ₹ 12.1m | |
| Company Secretary | 2.2yrs | ₹3.20m | no data | |
| Chief of Operational Excellence | 3.5yrs | ₹4.41m | 14.49% ₹ 2.1b | |
| Chief Technology Officer | 3.9yrs | ₹16.00m | 0.0046% ₹ 672.6k | |
| Compliance Officer | 2.2yrs | no data | no data | |
| Chief Marketing Officer | 3.9yrs | no data | no data | |
| Vice President of People & Culture | less than a year | no data | no data | |
| Head of Retail Sales | 8.3yrs | no data | no data | |
| Chief Product Officer | 1.9yrs | no data | no data | |
| Senior Vice President of Enterprise Sales | 1.8yrs | no data | no data |
Experienced Management: QUICKHEAL's management team is considered experienced (2.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 10.3yrs | ₹17.30m | 21.29% ₹ 3.1b | |
| Co-Founder | 10.3yrs | ₹16.80m | 35.78% ₹ 5.2b | |
| Non-Executive Independent Director | 6.5yrs | ₹1.24m | no data | |
| Independent Non-Executive Director | 4.3yrs | ₹1.00m | no data | |
| Independent Non-Executive Director | 1.4yrs | ₹120.00k | no data | |
| Independent Woman Director | less than a year | no data | no data |
Experienced Board: QUICKHEAL's board of directors are considered experienced (5.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/30 12:56 |
| End of Day Share Price | 2025/12/30 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Quick Heal Technologies Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kameswari V. S. Chavali | FirstCall Research |
| Vaibhav Dhasmana | Jefferies LLC |